Weiler, D., & Pérez Lago, M. d. S. (2024). Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma. European Journal of Nuclear Medicine & Molecular Imaging, 51(11), 3467. https://doi.org/10.1007/s00259-024-06747-1
Chicago Style (17th ed.) CitationWeiler, Daniela, and Maria del Sol Pérez Lago. "Successful Radioiodine Redifferentiation with Selpercatinib in RET Fusion-positive Papillary Thyroid Carcinoma." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 11 (2024): 3467. https://doi.org/10.1007/s00259-024-06747-1.
MLA (9th ed.) CitationWeiler, Daniela, and Maria del Sol Pérez Lago. "Successful Radioiodine Redifferentiation with Selpercatinib in RET Fusion-positive Papillary Thyroid Carcinoma." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 11, 2024, p. 3467, https://doi.org/10.1007/s00259-024-06747-1.